Tag: drug screening market trends

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Drug Screening Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The drug screening market has experienced substantial expansion in recent times. The market is anticipated to expand from $9.72 billion in 2025 to $11.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 15.0%. Historically, this growth was driven by factors such as the rise in workplace drug testing initiatives, the broadening of clinical trial endeavors, heightened screening demands from law enforcement, the proliferation of diagnostic laboratories, and the wider accessibility of rapid test kits.

The drug screening market size is projected to experience substantial growth over the next few years. It is anticipated to expand to $19.2 billion in 2030, with a compound annual growth rate (CAGR) of 14.5%. This growth during the forecast period is driven by factors such as the increasing adoption of AI-enabled screening analytics, a rising demand for portable drug testing devices, the expansion of regulatory drug compliance testing, the growing utilization of real-time reporting systems, and innovations in multi-panel drug screening. Significant trends expected in the forecast period include the increasing uptake of rapid drug testing kits, the rising use of automated laboratory screening systems, the growing integration of digital reporting solutions, the expansion of point-of-care drug testing, and an enhanced focus on high-accuracy detection.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=72144461&type=smp&name=Drug%20Screening%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Screening Market Growth Drivers: What’s Behind The Acceleration?

The increasing consumption of drugs and alcohol is anticipated to propel the expansion of the drug screening market in the coming period. Drug addiction is defined as a condition impacting an individual’s brain and behavior, leading to an inability to manage the use of either legal or illegal drugs or medications. Substances such as alcohol, marijuana, and nicotine are also classified as drugs. As addiction to drugs and alcohol rises, the likelihood of contracting diseases increases, which in turn fuels the necessity for drug screening. For instance, according to a June 2025 report from the Austria-based United Nations Office on Drugs and Crime, 316 million individuals, representing six percent of the population aged 15 to 64, used a drug (excluding alcohol and tobacco) in 2023. Cannabis remained the most prevalent drug, with 244 million users, followed by opioids at 61 million, amphetamines at 30.7 million, cocaine at 25 million, and “ecstasy” at 21 million. Therefore, the escalating intake of drugs and alcohol is a significant driver of growth for the drug screening market during the forecast period.

Drug Screening Market Segment Trends And Revenue Contributors

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Drug Screening Market Trends: What’s Defining The Industry’s Next Phase?

Leading companies active in the drug screening market are increasingly concentrating on forming strategic alliances and cooperative ventures to strengthen their financial standing, enhance their product portfolios, and broaden their geographic reach. A strategic collaboration entails an agreement between two or more entities to pursue a common set of objectives while each organization maintains its independent status. For instance, in February 2025, Neopharma Technologies, a Canada-based drug testing company, and Impairment Science, a United States-based cognitive assessment company, announced a strategic partnership designed to revolutionize drug and impairment testing. This collaboration merges Neopharma’s NEOVAULT platform, which digitally processes and reports rapid drug test results, with Impairment Science’s DRUID cognitive impairment assessment, an AI-driven tool for evaluating functional impairment. By integrating these two distinct technologies, the partnership aims to elevate the accuracy and relevance of drug screening, providing real-time insights into both drug presence and functional impairment. This joint effort could potentially enhance workplace safety, regulatory compliance, and decision-making in safety-sensitive environments through the application of AI and digital reporting technologies.

Drug Screening Market Top Companies Driving Competitive Growth

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

View The Full Drug Screening Market Report:

https://thebusinessresearchcompany.com/report/drug-screening-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Drug Screening Market Global Footprint: Which Region Leads The Industry?

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Drug Screening Market Expected To Scale Between 2026 And 2030?

The drug screening market size has experienced rapid growth in recent years. It is projected to expand from $9.72 billion in 2025 to $11.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. The historical growth of this market is attributable to a rise in workplace drug testing programs, an increase in clinical trial activities, heightened law enforcement screening requirements, the proliferation of diagnostic laboratories, and the broader availability of rapid test kits.

The drug screening market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach a valuation of $19.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This projected growth is driven by factors such as the increasing integration of AI-powered screening analytics, the escalating need for portable drug testing equipment, the broadening scope of regulatory drug compliance evaluations, the expanding application of real-time reporting platforms, and advancements in multi-panel drug screening methodologies. Key trends during this period encompass the widespread uptake of rapid drug testing kits, the increasing deployment of automated laboratory screening technologies, the greater incorporation of digital reporting tools, the wider availability of point-of-care drug testing, and an amplified emphasis on highly accurate detection methods.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What Factors Are Contributing To The Growth Of The Drug Screening Market?

The escalating intake of drugs and alcohol is anticipated to drive the expansion of the drug screening market in the coming period. Drug addiction is characterized as a condition impacting an individual’s brain and conduct, leading to an impaired capacity to regulate the intake of either legal or illicit drugs or medications. It is important to note that substances like alcohol, marijuana, and nicotine are also classified as drugs. With a rise in drug and alcohol addiction, there is an increased likelihood of developing diseases, thereby necessitating drug screening. As an illustration, data from June 2025 by the United Nations Office on Drugs and Crime, an Austria-based United Nations entity, indicated that 316 million individuals, or six percent of the population aged between 15 and 64, consumed a drug (excluding alcohol and tobacco) in 2023. Cannabis maintained its position as the most commonly used drug with 244 million users, trailed by opioids at 61 million, amphetamines at 30.7 million, cocaine at 25 million, and “ecstasy” at 21 million. Consequently, the escalating consumption of drugs and alcohol is serving as a primary impetus for the expansion of the drug screening market throughout the projected timeframe.

How Is The Drug Screening Market Categorized Across Its Segment Groups?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

What Trends Are Shaping The Future Of The Drug Screening Market?

Leading companies operating in the drug screening market are increasingly concentrating on strategic partnerships and collaborations to enhance their financial strength, bolster their product portfolios, and extend their geographical footprint. A strategic collaboration involves an agreement between two or more parties to pursue a defined set of objectives while retaining their independent organizational status. For instance, in February 2025, Neopharma Technologies, a Canada-based drug testing company, and Impairment Science, a United States-based cognitive assessment company, revealed a strategic partnership aimed at revolutionizing drug and impairment testing. This collaboration merges Neopharma’s NEOVAULT platform, which digitally processes and reports rapid drug test results, with Impairment Science’s DRUID cognitive impairment assessment, an AI-driven instrument for evaluating functional impairment. By integrating these two technologies, the partnership endeavors to improve the accuracy and relevance of drug screening, providing real-time insights not only into drug presence but also into functional impairment. This cooperative effort could potentially enhance workplace safety, regulatory adherence, and safety-sensitive decision-making by leveraging AI and digital reporting technologies.

Which Firms Are Influencing Competition In The Drug Screening Market?

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Get The Full Drug Screening Market Report:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Leads The Drug Screening Market In Terms Of Market Share?

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Drug Screening Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Pharmaceutical Label Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Drug Screening Market Over The 2026–2030 Period?

The drug screening market has experienced rapid expansion in recent years. Its size is projected to increase from $9.72 billion in 2025 to $11.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.0%. This growth in the past can be ascribed to several factors, including the rising number of workplace drug testing programs, the expansion of clinical trial activities, increased screening demands from law enforcement, the proliferation of diagnostic laboratories, and the broader access to rapid test kits.

The drug screening market is projected for substantial expansion in the coming years, with its size expected to grow to $19.2 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. This growth during the forecast period is primarily driven by factors such as the increasing adoption of AI-enabled screening analytics, a rising demand for portable drug testing devices, the expansion of regulatory drug compliance testing, the growing use of real-time reporting systems, and innovation in multi-panel drug screening. Major developments expected in the forecast period include the increasing adoption of rapid drug testing kits, the rising use of automated laboratory screening systems, the growing integration of digital reporting solutions, the expansion of point-of-care drug testing, and an enhanced focus on high-accuracy detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What Underlying Factors Are Accelerating The Growth Of The Drug Screening Market?

The rising consumption of drugs and alcohol is anticipated to fuel the expansion of the drug screening market in the foreseeable future. Drug addiction is a condition that impacts an individual’s brain and behavior, leading to an inability to manage the intake of legal or illegal drugs or medications. Substances like alcohol, marijuana, and nicotine are also classified as drugs. As drug and alcohol addiction rises, the likelihood of related diseases increases, thereby stimulating the demand for drug screening. For example, in June 2025, the United Nations Office on Drugs and Crime, an Austria-based UN organization, reported that 316 million people used a drug (excluding alcohol and tobacco) in 2023, which accounted for six percent of the population aged between 15 and 64. With 244 million users, cannabis remained the most commonly used drug, succeeded by opioids with 61 million users, amphetamines with 30.7 million users, cocaine with 25 million users, and “ecstasy” with 21 million users. Therefore, the increasing consumption of drugs and alcohol is a primary driver for the growth of the drug screening market throughout the forecast period.

How Is The Drug Screening Market Segmented Across Key Categories?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Which Upcoming Trends Are Expected To Influence The Drug Screening Market?

Leading firms within the drug screening market are increasingly prioritizing strategic alliances and joint ventures to enhance their financial stability, broaden their product offerings, and extend their global reach. Such collaborations involve an agreement where multiple entities work towards common goals while retaining their individual organizational autonomy. For example, in February 2025, Neopharma Technologies, a Canadian drug testing firm, and Impairment Science, a U.S.-based cognitive assessment company, declared a strategic partnership intended to transform drug and impairment screening. This joint effort integrates Neopharma’s NEOVAULT platform, which digitally processes and delivers rapid drug test outcomes, with Impairment Science’s DRUID cognitive impairment assessment, an AI-powered instrument designed for evaluating functional impairment. Through the fusion of these two technologies, the alliance seeks to boost the precision and applicability of drug screening, offering immediate data on both drug presence and functional impairment. This collaboration has the potential to enhance workplace safety, compliance with regulations, and decision-making in critical safety contexts by utilizing AI and digital reporting advancements.

Who Are The Dominant Players Shaping The Drug Screening Market Landscape?

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Read the full drug screening market report here:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Is Projected To Dominate The Drug Screening Market During The Forecast Period?

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Drug Screening Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Pharmaceutical Label Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Drug Screening Market size between 2026 and 2035?

The drug screening market size has expanded significantly in recent times. It is anticipated to increase from $9.72 billion in 2025 to $11.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. Historically, this growth can be linked to the rise in workplace drug testing programs, the expansion of clinical trial activities, increasing law enforcement screening requirements, the proliferation of diagnostic laboratories, and improved availability of rapid test kits.

The drug screening market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $19.2 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.5%. This anticipated growth during the forecast period is primarily due to factors such as the increasing adoption of AI-enabled screening analytics, a rising demand for portable drug testing devices, the expansion of regulatory drug compliance testing, the growing use of real-time reporting systems, and innovation in multi-panel drug screening. Major trends identified for the forecast period encompass the increasing adoption of rapid drug testing kits, the rising use of automated laboratory screening systems, the growing integration of digital reporting solutions, the expansion of point-of-care drug testing, and an enhanced focus on high-accuracy detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Which Drivers Are Impacting Market Performance In The Drug Screening Market?

Increasing drug and alcohol consumption is anticipated to propel the expansion of the drug screening market in the future. Drug addiction is defined as a condition affecting an individual’s brain and behavior, leading to an inability to control the use of legal or illegal substances or medications. Substances such as alcohol, marijuana, and nicotine are also categorized as drugs. As addiction to drugs and alcohol rises, the likelihood of diseases also increases, thereby stimulating the demand for drug screening. For instance, in June 2025, the United Nations Office on Drugs and Crime, an Austria-based United Nations office, reported that 316 million people, or six percent of the population aged between 15 and 64, used a drug (excluding alcohol and tobacco) in 2023. Cannabis remained the most widely used drug with 244 million users, followed by opioids (61 million), amphetamines (30.7 million), cocaine (25 million), and “ecstasy” (21 million). Consequently, the rising consumption of drugs and alcohol is driving the growth of the drug screening market during the forecast period.

Which Segments Are Contributing To The Growth Of The Drug Screening Market?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

What Trends Are Projected To Support The Growth Of The Drug Screening Market?

Leading companies in the drug screening market are increasingly concentrating on strategic alliances and cooperative ventures to bolster their financial strength, expand their product offerings, and extend their global footprint. A strategic collaboration signifies an agreement between two or more entities to pursue a defined set of objectives while maintaining their independent organizational structures. For example, in February 2025, Neopharma Technologies, a Canada-based drug testing firm, and Impairment Science, a United States-based cognitive assessment company, announced a strategic partnership aimed at transforming drug and impairment testing. This collaboration merges Neopharma’s NEOVAULT platform, which provides digital reading and reporting of rapid drug test results, with Impairment Science’s DRUID cognitive impairment assessment, an AI-driven tool for evaluating functional impairment. By integrating these two distinct technologies, the partnership endeavors to enhance the accuracy and relevance of drug screening, delivering real-time insights not only regarding drug presence but also functional impairment. This cooperative effort, by utilizing AI and digital reporting technologies, holds the potential to improve workplace safety, ensure better regulatory compliance, and facilitate more informed safety-sensitive decision-making.

Who Are The Top-Performing Companies In The Drug Screening Market In Recent Years?

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Drug Screening Market?

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Drug Discovery Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Pharmaceutical Label Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the drug screening market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Drug Screening Market By The End Of 2029?

The drug screening market has seen swift growth in its size over recent years. It is projected to increase from $8.57 billion in 2024 to $9.72 billion in 2025, achieving a compound annual growth rate (CAGR) of 13.3%. This expansion during the historic period can be ascribed to factors including pharmaceutical drug testing, advancements in healthcare and clinical diagnostics, efforts in substance abuse treatment, investments in research and development, and the growing usage of drug testing kits and devices.

The drug screening market is anticipated to experience substantial growth over the next few years. It is expected to expand to $16.86 billion by 2029, achieving a compound annual growth rate (CAGR) of 14.8%. This projected increase during the forecast period can be attributed to the legalization of cannabis and the ongoing opioid crisis, a rise in sports events, the development of point-of-care and rapid testing solutions, changes in drug policies and regulations, the expansion of workplace wellness and health programs, and international market outreach. Key trends expected in the forecast timeframe include advanced drug detection technologies, the rise of telemedicine and remote testing, investments in research and development, the introduction of innovative drug testing kits and devices, and general technological progress in testing methods.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Which Business Drivers Are Underpinning The Growth Of The Drug Screening Market?

An anticipated increase in drug and alcohol consumption is projected to drive the expansion of the drug screening market in the coming years. Drug addiction is a condition that impacts an individual’s brain and behavior, leading to an inability to manage the intake of legal or illegal drugs or medications. Substances like alcohol, marijuana, and nicotine are also classified as drugs. As addiction to drugs and alcohol rises, the likelihood of developing diseases also increases, thereby stimulating the demand for drug screening. For instance, in 2022, the worldwide issue of drug and alcohol consumption remained a significant concern. According to the National Survey on Drug Use and Health (NSDUH), 13.5% of Americans aged 12 and over reported drug use in the last month, indicating a 3.8% year-over-year increase. Moreover, the report further stated that 59.277 million, or 21.4%, of people aged 12 and over had used illegal drugs or misused prescription drugs within the previous year. The effects of the pandemic also exacerbated drug risks, with cannabis intake among youth increasing by as much as four times in various parts of the world. Consequently, the escalating consumption of drugs and alcohol is fueling the growth of the drug screening market throughout the forecast period.

What Are The Principal Segment Types In The Drug Screening Market?

The drug screeningmarket covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

How Are Industry Trends Steering The Expansion Of The Drug Screening Market?

The introduction of innovative products is a significant trend gaining traction in the drug screening market. Key players in the drug screening market are concentrating on developing and launching advanced products to satisfy rapidly expanding industry demand and reinforce their market position. Moreover, the COVID-19 pandemic prompted a sudden alteration in the drug screening approach, which transformed screening methodologies and spurred companies towards innovation and the creation of new products. Companies are dedicated to developing novel products, such as more effective drug tests that can be extensively utilized by laboratories. For instance, in September 2022, Sysmex Corporation, a Japan-based healthcare company, unveiled the UF-1500 Fully Automated Urine Particle Testing Analyzer, a new product intended for urine sediment testing and screening. The UF-1500 incorporates the superior functionality and ease of use found in the UF-5000 Fully Automated Urine Particle Analyzer, Sysmex’s leading model in urine sediment testing, while achieving a more compact form compared to the previous model.

Which Companies Are Contributing Significantly To The Drug Screening Market Growth?

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Offers The Most Opportunity For Drug Screening Market Expansion?

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2025, By The Business Research Company

Data Protection As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report

Cloud Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report

Application Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#How Much Was The Drug Screening Market Worth In 2025, And What Is Its Anticipated Value By 2029?#_x000D_

The sector for drug screening has experienced swift expansion over the last few years, projected to increase its valuation from $8.57 billion in 2024 to $9.72 billion come 2025, signifying a compounded annual growth rate of 13.3%. This upward trajectory observed during the past period is fueled by numerous factors, including pharmaceutical drug evaluation processes, advancements in healthcare and laboratory diagnostics, the expansion of substance misuse rehabilitation services, greater financial allocations toward research initiatives, and the wider adoption of various drug testing instruments and kits._x000D_

_x000D_

Anticipating substantial expansion in the coming years, the domain of drug screening is projected to reach a valuation of $16.86 billion by 2029, driven by a compound annual growth rate (CAGR) of 14.8%; this upward trajectory across the forecast horizon is fueled by several key factors, notably the growing permissiveness surrounding cannabis, the ongoing opioid epidemic, a rise in the number of sporting competitions, the proliferation of rapid and point-of-care diagnostic methods, evolving governmental mandates and compliance frameworks regarding substance use, the development of employee health and wellness initiatives, and the broadening reach into global territories._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp_x000D_

_x000D_

#What Are The Drivers Pushing New Developments In The Drug Screening Market?#_x000D_

The escalating prevalence of substance abuse involving both illicit drugs and alcohol is anticipated to be a primary impetus behind the future expansion of the drug screening industry. Drug addiction, fundamentally a disorder impacting neurological function and conduct, manifests as an inability to manage the intake of prescription medications or illicit narcotics; this category also encompasses substances like nicotine and marijuana. The rise in dependency on these substances correlates directly with heightened disease incidence, thereby necessitating increased drug testing protocols. To illustrate this trend, global concerns regarding substance utilization remained notably high in 2022. Data presented by the National Survey on Drug Use and Health (NSDUH) pointed out that in the United States, 13.5% of individuals aged twelve and above reported substance use in the preceding month, representing a year-over-year uptick of 3.8%. Furthermore, a significant portion, specifically 59.277 million people, equating to 21.4% of those aged twelve years or more, admitted to using illegal substances or misusing prescribed drugs within the last year. Compounding this situation, the ramifications of the recent pandemic saw the risks associated with drug use amplified, evidenced by up to a fourfold surge in cannabis consumption among younger populations in specific global regions. Consequently, this pervasive upward trajectory in the consumption of intoxicants and drugs is directly fueling the market’s anticipated growth throughout the forecast tenure._x000D_

_x000D_

#How Is The Drug Screening Market Classified Into Different Segments?#_x000D_

The drug screeningmarket covered in this report is segmented – _x000D_

_x000D_

1) By Products: Rapid Testing Devices, Consumables, Other Products_x000D_

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types_x000D_

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges_x000D_

_x000D_

Subsegments:_x000D_

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips _x000D_

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards _x000D_

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions_x000D_

_x000D_

#How Are Emerging Market Trends Shaping The Drug Screening Industry Landscape?#_x000D_

A significant trend currently observed within the drug screening market involves the introduction of novel solutions, with leading market participants prioritizing the creation and release of cutting-edge offerings to satisfy escalating industry needs and enhance their competitive standing; furthermore, the implications of the COVID-19 pandemic instigated an abrupt shift in how drug screening is managed, consequently altering established testing procedures and stimulating greater corporate endeavors toward invention and the creation of fresh products, as firms endeavor to engineer superior, universally applicable drug testing mechanisms for laboratories; as an illustration of this, in September 2022, Japan’s Sysmex Corporation unveiled the UF-1500 Fully Automated Urine Particle Testing Analyzer, a new device designed for urine sediment analysis and screening, which retains the high operational capability and user-friendliness characteristic of their premier urine sediment testing instrument, the UF-5000, whilst concurrently achieving a more compact physical size compared to its predecessor._x000D_

_x000D_

#Who Are The Top Performing Companies In The Drug Screening Market In Recent Years?#_x000D_

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report_x000D_

_x000D_

#Which Region Currently Holds The Largest Share Of The Drug Screening Market?#_x000D_

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Drug Screening Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Drug Screening Market 2025, By The Business Research Company#_x000D_

_x000D_

Data Protection As A Service Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report_x000D_

_x000D_

Cloud Security Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report_x000D_

_x000D_

Application Security Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Drug Screening Market Size from 2025 to 2034?

In recent years, there has been substantial growth in the size of the drug screening market. Forecasts predict an increase from $8.57 billion in 2024 to $9.72 billion in 2025, implying a compound annual growth rate (CAGR) of 13.3%. The historic growth rate can be credited to factors such as the testing of pharmaceutical drugs, advancements in healthcare and clinical diagnosis, the treatment of substance abuse, investments in research and development, and the rising demand for drug testing kits and devices.

Expectations for the drug screening market size forecast a swift increase over the coming years. By 2029, it’s projected to reach $16.86 billion with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to this growth during the forecast period include the legalization of cannabis and the opioid crisis, rising sports events, advancements in point-of-care and rapid testing, changes in drug policies and regulations, an increase in workplace wellness and health programs, and expansion of the international market. Key trends during this period will encompass advanced drug detection technologies, the growth of telemedicine and remote testing, investment in research and development, the introduction of innovative drug testing kits and devices, and progress in testing technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What are the Fundamental Drivers and Innovations Shaping the Drug Screening Market?

The increase in drug and alcohol consumption is anticipated to fuel the expansion of the drug screening market. Drug addiction, a disease that impacts a person’s brain and behavior, leads to an inability to regulate the use of lawful or illicit drugs or medication. This category includes substances like alcohol, marijuana, and nicotine. As the incidence of drug and alcohol addiction rises, it creates a higher risk of disease, necessitating drug testing. For example, in 2022, the issue of drug and alcohol use remained a major global worry. The National Survey on Drug Use and Health (NSDUH) reported that 13.5% of Americans aged 12 and older consumed drugs in the previous month, reflecting a 3.8% annual rise. Additionally, the survey reveals that 59.277 million people, or 21.4% of those aged 12 and above, have consumed illegal drugs or misused prescription medication in the past year. The pandemic has also heightened drug risks, with cannabis use among young people increasing fourfold in some parts of the world. Hence, the surge in drug and alcohol consumption is propelling the growth of the drug screening market in the forecast period.

How Is the Drug Screening Market Segmented?

The drug screeningmarket covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Which Regions Are Driving the Next Phase of the Drug Screening Market Growth?

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the Drug Screening Market?

The introduction of pioneering products is an emerging trend expanding its prominence in the drug screening market. To fulfill the rapidly escalating industry requirements and solidify their market standing, major firms in the drug screening market are concentrating their efforts on the creation and introduction of novel products. The COVID pandemic brought about a drastic shift in the methodology of drug screening, spurring innovation and the development of novel products by enterprises. Companies are battling to create new offerings like improved drug tests that are more effective and have the potential to be extensively adopted by labs. For example, in September 2022, Sysmex Corporation, the healthcare company from Japan, introduced the UF-1500 Fully Automated Urine Particle Testing Analyzer, a novel product designed for urine sediment testing and screening. The UF-1500 carries forward the sophisticated functionality and user-friendliness of UF-5000 Fully Automated Urine Particle Analyzer, which is Sysmex’s premier model for urine sediment testing, while also being compacter than the previous model.

View the full report here:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

How Is the Drug Screening Market Defined and What Are Its Core Parameters?

Drug screening is an approach used for drug testing, identified and optimized for clinical trials used in the analysis of blood, urine, hair, or saliva to detect the presence of chemicals and pollutants and other illicit substance left in the body as a result of drug usage.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Drug Screening Market?

The escalation in the usage of drugs and alcohol is projected to push forward the expansion of the drug screening market. Drug dependency is defined as a malady that impacts a person’s cognitive function and conduct, leading to an inability to manage the utilization of a lawful or illicit drug or medication. Alcohol, marijuana, and nicotine are also classified as drugs. When the prevalence of drug and alcohol addiction rises, the likelihood of disease also escalates, necessitating drug screening. For example, in 2022, the global concern over drug and alcohol consumption persists. The National Survey on Drug Use and Health (NSDUH) reveals that 13.5% of Americans aged 12 and older had consumed drugs in the previous month, displaying a 3.8% increment from the previous year. The report further highlights that 59.277 million, or 21.4%, of individuals aged 12 and over had illicitly used drugs or abused prescription drugs in the past year. The fallout from the pandemic exacerbated drug risks, with the intake of cannabis amongst young people rising by as much as quadruple in certain regions. Consequently, the rise in drug and alcohol usage is fueling the expansion of the drug screening market during the projection period.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

#What Are the Key Projections for the CAGR of the Drug Screening Market From 2025 to 2034?

In recent times, the drug screening market has expanded at a quick pace. There will be an escalation from $8.57 billion in 2024 to $9.79 billion in 2025, with a compound annual growth rate (CAGR) of 14.2%. The historic period’s expansion was driven by factors such as pharmaceutical drug examination, healthcare and clinical diagnostics, treatments for substance abuse, investments in research and development, and a rise in the utilization of drug testing kits and tools.

Anticipated to witness a swift expansion in the upcoming years, the drug screening market is set to surge to a value of $17.1 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. The predicted expansion in the forecast period is driven by factors such as the legal acceptance of cannabis and the opioid crisis, the increase in sports events, point-of-care and rapid testing, evolving drug legislations and regulations, the growth of workplace health and wellness programs, and global market growth. The major trends expected in the forecast period are cutting-edge drug recognition technologies, the growth of telemedicine and remote testing, investment into research and development, the innovation of drug testing kits and devices, and technological progression in testing methods.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

What Are the Key Market Innovations in theDrug Screening Market Over the Coming Years?

Innovation and introduction of new products are significant trends that are gaining traction in the drug screening market. Major businesses in this sector are concentrating their resources on product development and innovation to suit the rapidly growing industry needs and reinforce their market standing. The unexpected shift of drug screening methods due to COVID-19 has spurred the innovation and development of newer products. Businesses are trying hard to create more efficient, widely-accepted drug tests. As an illustration, in September 2022, Sysmex Corporation, a healthcare company based in Japan, introduced the UF-1500 Fully Automated Urine Particle Testing Analyzer. This new device, used in urine sediment testing and screening, combines the robust features and user-friendly design of the UF-5000, the company’s leading urine sediment testing model, whilst being more compact than the earlier model.

Who Are the Top Companies Driving Innovation and Growth in theDrug Screening Market?

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Key Market Segments Comprise the Drug Screening Market and Drive Its Revenue Growth?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Which Regions Are Emerging as Leaders in the Drug Screening Market?

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Gobal Drug Screening Maret 2025, By The Business Research Company:

Security and Vulnerability Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-and-vulnerability-management-global-market-report

Application Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Managed Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/managed-security-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the drug screening market right now?

In recent times, the drug screening market size has seen expedited growth, set to increase from $8.57 billion in 2024 to $9.79 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.2%. The accelerated growth during the historical timeframe is due to factors such as pharmaceutical drug examination, healthcare and clinical diagnostics, addiction therapy, investments in research and development, and the expanded usage of drug testing kits and apparatus.

How fast Is the drug screening market expected to grow, and what’s its future value?

Expectations are high for the drug screening market to experience significant expansion in the coming years. The market is predicted to reach $17.1 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.0%. This anticipated expansion during the forecast period can be credited to factors such as the legalization of cannabis and the opioid crisis, an increase in sports events, point-of-care and rapid testing advancements, the evolution of drug policies and regulations, the expansion of wellness and health programs in workplaces, and global market growth. Notable trends for the forecast period include advancements in drug detection technology, the rise of telemedicine and remote testing, increased investment in research and development, the introduction of innovative drug testing kits and devices, and technological progress in testing practices.

Get your drug screening market report here!

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

What are the leading drivers of growth in the drug screening market?

The increase in drug and alcohol consumption globally is predicted to boost the expansion of the drug screening market. Drug addiction, defined as a disease that impacts a person’s brain and behavior making it difficult to regulate the use of legal or illegal drugs or medications, considers substances like alcohol, marijuana, and nicotine as drugs. With the growth in drug and alcohol addiction, the risk of disease also rises, hence stimulating the necessity for drug screening. For example, in 2022, the high instance of drug and alcohol misuse remained a major global issue. The National Survey on Drug Use and Health (NSDUH) reveals that 13.5% of Americans aged 12 and above consumed drugs in the past month, indicating a 3.8% yearly growth. The study further illustrates that about 59.277 million people or 21.4% of individuals aged 12 and above have abused illegal drugs or improperly used prescription drugs over the past year. Increased drug risks due to the pandemic are concerning, with reported youth cannabis intake rising up to four times in some parts of the world. Therefore, the upsurge in drug and alcohol usage is pushing the growth of the drug screening market during the forecast period.

What are the key segments defining the drug screening market?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Who are the key players steering the development of the drug screening market?

Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

What emerging trends are influencing the growth of the drug screening market?

A prominent trend emerging in the drug screening market is the introduction of cutting-edge products. Key players in this sector are focusing on creating and introducing unique products to cater to the swiftly increasing market needs and bolster their position in the industry. The COVID-19 pandemic has expedited this trend with a swift shift in drug screening methods, fostering ingenuity and novel product development among companies. Businesses are making an effort to create improved drug tests that laboratories can utilize widely. For instance, Sysmex Corporation, a healthcare firm from Japan, in September 2022, introduced the UF-1500 Fully Automated Urine Particle Testing Analyzer. This new device is purpose-built for urine sediment testing and screening and is compact than the earlier model, the UF-5000, while retaining its high functionality and user-friendly nature.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

Which regions are most influential in expanding the drug screening market?

North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Security and Vulnerability Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-and-vulnerability-management-global-market-report

Application Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Managed Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/managed-security-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: